CIBC Private Wealth Group’s Dr. Reddy's Laboratories RDY Stock Holding History

CIBC Private Wealth Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$6.74K	Hold	480	–	–	﹤0.01%	2552
2025 Q3	$6.71K	Hold	480	–	–	﹤0.01%	2501
2025 Q2	$7.21K	Buy	480 +155	+48%	+$2.21K	﹤0.01%	2362
2025 Q1	$4.04K	Buy	+325	New	+$4.48K	﹤0.01%	2511
2024 Q4	–	Sell	-445	Closed	-$7.07K	–	3146
2024 Q3	$7.07K	Buy	445 +215	+93%	+$3.46K	﹤0.01%	2500
2024 Q2	$3.57K	Hold	230	–	–	﹤0.01%	2627
2024 Q1	$3.4K	Buy	+230	New	+$3.36K	﹤0.01%	2614

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

CIBC Private Wealth Group's RDY Position: Q4 2025 in Review

CIBC Private Wealth Group held its Dr. Reddy's Laboratories (RDY) position steady in Q4 2025 at 480 shares worth $6.74K. The position accounts for ﹤0.01% of the portfolio, ranked #2552.

CIBC Private Wealth Group first reported a position in RDY in Q1 2024 and has held it in 7 quarters since. The position peaked at $7.21K in Q2 2025. 235 funds tracked by Wall St. Rank hold RDY as of Q4 2025.

CIBC Private Wealth Group held 480 shares of Dr. Reddy's Laboratories worth $6.74K as of Q4 2025.
CIBC Private Wealth Group left its Dr. Reddy's Laboratories share count unchanged in Q4 2025.
Dr. Reddy's Laboratories made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2552 holding.
CIBC Private Wealth Group first reported a position in Dr. Reddy's Laboratories in Q1 2024 and has held it in 7 quarters since.
CIBC Private Wealth Group's Dr. Reddy's Laboratories position peaked at $7.21K in Q2 2025.
235 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.